Open AccessEffects of zoledronic acid therapy in fibrous dysplasia of bone: a single-center experience
Author(s) -
Luciana Pinto Valadares,
Bruno Silva de Araújo Ferreira,
Bernardo Matos da Cunha,
Luiza Beatriz Melo Moreira,
Frederico Batista,
Cristiane da Fonseca Hottz,
Gabriel Galvão Rafael Magalhães
Publication year - 2022
Publication title -
archives of endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.582
H-Index - 50
eISSN - 2359-4292
pISSN - 2359-3997
DOI - 10.20945/2359-3997000000459
Subject(s) - medicine , zoledronic acid , bone pain , adverse effect , radiological weapon , single center , bone remodeling , fibrous dysplasia , urology , surgery
Fibrous dysplasia (FD) is a rare bone disorder that can involve any part of the skeleton, leading to bone pain, deformities, and fractures. Treatment with intravenous bisphosphonates has been used with variable results. Therefore, we aimed to evaluate the effects of zoledronic acid (ZA) therapy in patients with monostotic or polyostotic FD.